This item is under embargo and not available online per the author's request. For access information, please visit http://libanswers.wustl.edu/faq/5640.

ORCID

http://orcid.org/0000-0003-2235-5673

Date of Award

Spring 5-15-2021

Author's School

Graduate School of Arts and Sciences

Author's Department

Biology & Biomedical Sciences (Molecular Genetics & Genomics)

Degree Name

Doctor of Philosophy (PhD)

Degree Type

Dissertation

Abstract

Brain development requires exquisite control of gene expression to establish and refine the proper circuitry of the nervous system. Gene expression control is under the purview of several cellular processes, including chromatin regulation in the form of DNA modification, histone modification, and nucleosome remodeling. Chromatin remodeling enzymes are the major effectors of nucleosome remodeling. These enzymes are clearly involved in brain development – mutations in chromatin remodeling enzymes are likely causative for neurodevelopmental disorders of cognition. Chromatin remodeling enzymes have discrete molecular functions and binding profiles and similarly control distinct phases of nervous system maturation. Chd4 is a Chd family chromatin remodeling enzyme that is mutated in Sifrim-Hitz-Weiss intellectual disability syndrome and is critical for neuronal differentiation. Chd4 binds to active regulatory elements, including promoters and enhancers, to putatively restrict genomic accessibility and repress gene expression. Work on Chd4 in the brain has revealed pathways of gene regulation that impact gene promoters, but the function of Chd4 at enhancers, and their effects on promoters through three-dimensional genomic interactions, in the developing brain remains poorly understood.

Language

English (en)

Chair and Committee

Azad Bonni Harrison Gabel

Committee Members

Azad Bonni, Harrison W. Gabel, Aaron DiAntonio, Milan G. Chheda,

Available for download on Sunday, May 15, 2022

Share

COinS